IL149004A0 - Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents - Google Patents
Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agentsInfo
- Publication number
- IL149004A0 IL149004A0 IL14900400A IL14900400A IL149004A0 IL 149004 A0 IL149004 A0 IL 149004A0 IL 14900400 A IL14900400 A IL 14900400A IL 14900400 A IL14900400 A IL 14900400A IL 149004 A0 IL149004 A0 IL 149004A0
- Authority
- IL
- Israel
- Prior art keywords
- targeted
- iron
- biologically active
- active agents
- porous materials
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ceramic Engineering (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Paints Or Removers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16029399P | 1999-10-18 | 1999-10-18 | |
| PCT/US2000/028615 WO2001028587A2 (en) | 1999-10-18 | 2000-10-13 | Magnetic targeted carrier |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL149004A0 true IL149004A0 (en) | 2002-11-10 |
Family
ID=22576298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14900400A IL149004A0 (en) | 1999-10-18 | 2000-10-13 | Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1221974A2 (en) |
| JP (3) | JP2003512336A (en) |
| KR (1) | KR20020064299A (en) |
| CN (1) | CN1287859C (en) |
| AU (1) | AU772755B2 (en) |
| BR (1) | BR0014877A (en) |
| CA (1) | CA2387925A1 (en) |
| CZ (1) | CZ293919B6 (en) |
| DE (1) | DE1221974T1 (en) |
| ES (1) | ES2182731T1 (en) |
| HK (1) | HK1045110A1 (en) |
| IL (1) | IL149004A0 (en) |
| MX (1) | MXPA02003891A (en) |
| NZ (1) | NZ518311A (en) |
| WO (1) | WO2001028587A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9808052D0 (en) | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
| EP1668424A4 (en) * | 2003-09-12 | 2009-11-25 | Onkor Pharmaceuticals Inc | Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| JP2007001865A (en) * | 2003-09-16 | 2007-01-11 | Ltt Bio-Pharma Co Ltd | Fine particle enclosing fat-soluble medicine, method for producing the same and preparation containing the same |
| JP4982084B2 (en) * | 2004-02-09 | 2012-07-25 | 株式会社サンギ | Antitumor agent |
| WO2005079867A2 (en) * | 2004-02-20 | 2005-09-01 | Algeta As | Alpha-emitting hydroxyapatite particles |
| GB0403856D0 (en) * | 2004-02-20 | 2004-03-24 | Algeta As | Composition |
| JP2006199810A (en) * | 2005-01-20 | 2006-08-03 | Yokohama National Univ | Composite particle and method for producing the same |
| US8293274B2 (en) | 2005-04-06 | 2012-10-23 | Kabushiki Kaisha Sangi | Intestinal absorptive anti-tumor agent |
| CA2758607C (en) | 2009-05-04 | 2018-05-15 | Psivida Us, Inc. | Porous silicon drug-eluting particles |
| US9333173B2 (en) | 2010-11-01 | 2016-05-10 | Psivida Us, Inc. | Bioerodible silicon-based devices for delivery of therapeutic agents |
| JP6170154B2 (en) * | 2012-08-28 | 2017-07-26 | バイオキューブシステム インコーポレイテッド | Porous solid phase and its use for rapid separation of biological molecules for nucleic acid amplification reactions from biological samples |
| CA2904077A1 (en) | 2013-03-15 | 2014-09-25 | Psivida Us, Inc. | Bioerodible silicon-based compositions for delivery of therapeutic agents |
| JP6443907B2 (en) * | 2014-02-17 | 2018-12-26 | 浩文 山本 | Accumulation promoter for promoting accumulation of contrast agent in tumor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4243652A (en) * | 1978-07-14 | 1981-01-06 | The Procter & Gamble Company | Gastrointestinal scanning agent |
| ES2066851T3 (en) * | 1988-05-24 | 1995-03-16 | Anagen Uk Ltd | MAGNETICALLY ATTRIBUTABLE PARTICLES AND METHOD OF PREPARATION. |
| DE59508069D1 (en) * | 1994-07-27 | 2000-04-27 | Herbert Pilgrimm | SUPERPARAMAGNETIC PARTICLES, METHOD FOR THE PRODUCTION AND USE THEREOF |
| WO1997001304A1 (en) * | 1995-06-29 | 1997-01-16 | Mallinckrodt Medical, Inc. | Radiolabeled apatite particles containing a paramagnetic ion |
| JP3735990B2 (en) * | 1997-01-28 | 2006-01-18 | 東ソー株式会社 | Method for producing magnetic silica gel |
-
2000
- 2000-10-13 AU AU10905/01A patent/AU772755B2/en not_active Ceased
- 2000-10-13 NZ NZ518311A patent/NZ518311A/en unknown
- 2000-10-13 CN CNB008173796A patent/CN1287859C/en not_active Expired - Fee Related
- 2000-10-13 WO PCT/US2000/028615 patent/WO2001028587A2/en not_active Application Discontinuation
- 2000-10-13 JP JP2001531415A patent/JP2003512336A/en active Pending
- 2000-10-13 IL IL14900400A patent/IL149004A0/en unknown
- 2000-10-13 CA CA002387925A patent/CA2387925A1/en not_active Abandoned
- 2000-10-13 MX MXPA02003891A patent/MXPA02003891A/en not_active Application Discontinuation
- 2000-10-13 CZ CZ20021357A patent/CZ293919B6/en not_active IP Right Cessation
- 2000-10-13 BR BR0014877-6A patent/BR0014877A/en not_active IP Right Cessation
- 2000-10-13 ES ES00972209T patent/ES2182731T1/en active Pending
- 2000-10-13 DE DE1221974T patent/DE1221974T1/en active Pending
- 2000-10-13 EP EP00972209A patent/EP1221974A2/en not_active Withdrawn
- 2000-10-13 KR KR1020027004933A patent/KR20020064299A/en active Search and Examination
-
2002
- 2002-09-05 HK HK02106551.6A patent/HK1045110A1/en unknown
-
2003
- 2003-03-10 JP JP2003063821A patent/JP2003321348A/en not_active Withdrawn
-
2005
- 2005-03-28 JP JP2005093293A patent/JP2005200426A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2387925A1 (en) | 2001-04-26 |
| DE1221974T1 (en) | 2003-02-06 |
| AU772755B2 (en) | 2004-05-06 |
| EP1221974A2 (en) | 2002-07-17 |
| MXPA02003891A (en) | 2002-12-09 |
| JP2003321348A (en) | 2003-11-11 |
| BR0014877A (en) | 2002-06-11 |
| WO2001028587A2 (en) | 2001-04-26 |
| JP2005200426A (en) | 2005-07-28 |
| AU1090501A (en) | 2001-04-30 |
| KR20020064299A (en) | 2002-08-07 |
| CZ20021357A3 (en) | 2002-11-13 |
| CZ293919B6 (en) | 2004-08-18 |
| JP2003512336A (en) | 2003-04-02 |
| WO2001028587A3 (en) | 2002-01-03 |
| CN1420787A (en) | 2003-05-28 |
| CN1287859C (en) | 2006-12-06 |
| HK1045110A1 (en) | 2002-11-15 |
| ES2182731T1 (en) | 2003-03-16 |
| NZ518311A (en) | 2003-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142807A0 (en) | Controlled delivery of active agents | |
| EP1183068A4 (en) | Method of electroporation-enhanced delivery of active agents | |
| IL155204A0 (en) | Compositions and methods for the transport of biologically active agents across cellular barriers | |
| IL143962A0 (en) | Polymeric delivery agents and delivery agent compounds | |
| GB2373477B (en) | Nonwoven fabrics providing controlled active agent delivery | |
| EP0979225A4 (en) | Compounds and compositions for delivering active agents | |
| IL143857A0 (en) | Transdermal delivery of fine powders | |
| EP1162952A4 (en) | Cytoprotective biocompatible containment systems for biologically active materials and methods of making same | |
| IL149004A0 (en) | Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents | |
| HUP0103188A2 (en) | Compounds and compositions for delivering active agents | |
| IL129427A0 (en) | Preparation of biologically active molecules | |
| AU8166098A (en) | Removal of biologically active agents | |
| EP1154997A4 (en) | Pharmaceutically active compounds and methods of use thereof | |
| EP1148107A4 (en) | Coated biologically active grains | |
| IL146795A0 (en) | Biologically active materials | |
| IL148252A0 (en) | Biodegradable solutions of biologically active compounds | |
| AU6269901A (en) | Biologically active agents and drugs | |
| AU2001262699A1 (en) | Biologically active agents and drugs | |
| GB9814851D0 (en) | Biologically and therapeautically active agents | |
| GB9915380D0 (en) | Biologically and therapeutically active agents | |
| GB9814238D0 (en) | Biologically and therapeutically active agents | |
| PL352211A1 (en) | Biologically active materials | |
| GB0019101D0 (en) | Biologically and therapeutically active agents | |
| GB0019100D0 (en) | Biologically and therapeutically active agents | |
| GB9711697D0 (en) | Biologically and therapeutically active agents |